Alberto Pavan et. al., Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome.

Diatech Pharmacogenetics 2020-11-03T15:06:20+00:00